Physician profile
Jared B Barton
NPI 1144328949
$397.06
in general payments reported to CMS, 2019-2025
11 companies · $53.65 in 2025
The $53.65 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.78 · 2021: $51.50 · 2022: $88.38 · 2023: $41.66 · 2024: $124 · 2025: $53.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $219.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $124.09 | 2024 | Ovitex 2s |
| Medtronic, INC. | $75.40 | 2022-2023 | Venaseal |
| Regeneron Healthcare Solutions, INC. | $56.94 | 2023-2025 | Dupixent |
| Lilly USA, LLC | $26.20 | 2019 | |
| Supernus Pharmaceuticals, INC. | $23.50 | 2021 | |
| Innocoll Pharmaceuticals Limited | $18.77 | 2022 | |
| Braintree Laboratories, INC. | $17.11 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $15.69 | 2021 | |
| Exact Sciences Corporation | $15.47 | 2025 | Cologuard Collection Kit |
| Welch Allyn | $12.31 | 2021 | |
| Ferring Pharmaceuticals INC. | $11.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Barton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.